ProteoMediX AG

Wagistr. 23
8952 Schlieren
Display on the map

Employee CH: 6
Sector: Chemicals/Pharmaceuticals
Revenue last year: No information available
Stock exchange: No information available
Further information

ProteoMediX is a spinoff company of ETH Zurich and specialized in the development of novel biomarkers for the early detection of cancer and the personalized treatment thereof.
The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinical standard. This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.

Full description

Current Vacancies at ProteoMediX AG